Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 05, 2007 10:55 ET | Source: Samaritan Pharmaceuticals, Inc.

Samaritan Pharma Strategically Advances Its Promising Alzheimer's Drug

Enters Service Agreement With Advinus Therapeutics, India to Validate Potential Memory Restoring Benefits of Alzheimer's Drug Caprospinol Strategy is to Bolster Caprospinol Alzheimer's Data...
March 01, 2007 09:56 ET | Source: Samaritan Pharmaceuticals, Inc.

Samaritan Pharma Completes Acquisition of Metastatin Pharmaceuticals

LAS VEGAS, March 1, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV), a developer of innovative drugs, is pleased to announced today that the company has closed its acquisition of...
February 26, 2007 10:24 ET | Source: Samaritan Pharmaceuticals, Inc.

Shire plc Signs Marketing Agreement With Samaritan Pharma

LAS VEGAS, Feb. 26, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV) a developer of innovative drugs, is pleased to announce it has signed a marketing and distribution agreement,...
February 22, 2007 09:53 ET | Source: Samaritan Pharmaceuticals, Inc.

Samaritan Pharma Files Patent to Protect SP-04 as Bioterrorism Nerve Gas Antidote

LAS VEGAS, Feb. 22, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV), a developer of innovative drugs, is pleased to announce it has filed a patent application to protect SP-04 as a...
February 06, 2007 12:05 ET | Source: Samaritan Pharmaceuticals, Inc.

Samaritan Pharma Aims At SP-6300 as New Innovative Treatment for Cushing's Syndrome

Files New Patent Application for SP-6300 Making Use of SP-01A's Phase II Study Data Drug SP-01A (HIV), SP-6300 (Cushing's) Demonstrates a Statistically ...
February 02, 2007 18:01 ET | Source: Samaritan Pharmaceuticals, Inc.

Samaritan Pharma Requests Hearing Before AMEX's Listing Qualifications Panel to Appeal Non-Acceptance of Company's Compliance Plan

LAS VEGAS, Feb. 2, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV), a developer of innovative drugs, announces it has requested a hearing before the AMEX's listing qualifications...
January 25, 2007 12:33 ET | Source: Samaritan Pharmaceuticals, Inc.

Samaritan Pharma's SP-10 Hip On Hep C

* National Institutes of Allergy and Infectious Diseases (NIAID) Finds Significant Antiviral Activity With Entry Inhibitor SP-10 for Hepatitis C Virus (HCV) * "Oral" Antiviral Entry...
January 22, 2007 10:54 ET | Source: Samaritan Pharmaceuticals, Inc.

Breath of Life Product In-Licensed to Samaritan Pharma

* ONY's Neonatal U.S. Approved Drug Infasurf to Treat Respiratory Distress Syndrome in Premature Infants In-Licensed * Marketing and Sales Rights Granted for Turkey, Serbia, Bosnia, ...
January 16, 2007 10:33 ET | Source: Samaritan Pharmaceuticals, Inc.

Samaritan Pharma In-Licenses Rights to Promote and Sell Six of Molteni's Prescription Drugs for Pain, Drug Addiction and Anesthesia in Greece and Cyprus

LAS VEGAS, Jan. 16, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV), a developer of innovative drugs, is pleased to announce that it has signed an exclusive license with Molteni...
December 07, 2006 10:15 ET | Source: Samaritan Pharmaceuticals, Inc.

FDA Grants IND to Samaritan's Novel Plaque Clearing Alzheimer's Drug and Requests Additional Information Be Provided Before Starting Its Proposed Phase I Trial

LAS VEGAS, Dec. 7, 2006 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV), a developer of innovative drugs, announced that the U.S. Food and Drug Administration (FDA) has completed its...